On the 30th, SHINPOONG Pharm's stock price is rising over 19%. This follows news that it has acquired domestic patents related to infectious RNA virus diseases such as COVID-19.
As of 9:50 a.m. on the 30th, SHINPOONG Pharm is trading at 15,450 won, up 2,520 won (19.49%) from the previous trading day.
Previously, SHINPOONG Pharm announced on the 27th that it had registered a patent in Korea for a pharmaceutical composition for the prevention or treatment of infectious RNA virus diseases.
According to SHINPOONG Pharm, the composition can be used for the prevention or treatment of infectious RNA virus diseases, particularly COVID-19.
※ This article has been translated by AI. Share your feedback here.